125 related articles for article (PubMed ID: 36385618)
1. Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors.
Merli P; Crivello P; Strocchio L; Pinto RM; Algeri M; Del Bufalo F; Pagliara D; Becilli M; Carta R; Gaspari S; Galaverna F; Quagliarella F; Boz G; Catanoso ML; Boccieri E; Troiano M; Fleischhauer K; Andreani M; Locatelli F
Br J Haematol; 2023 Mar; 200(5):622-632. PubMed ID: 36385618
[TBL] [Abstract][Full Text] [Related]
2. Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
Daull AM; Dubois V; Labussière-Wallet H; Venet F; Barraco F; Ducastelle-Lepretre S; Larcher MV; Balsat M; Gilis L; Fossard G; Ghesquières H; Heiblig M; Ader F; Alcazer V
Front Immunol; 2022; 13():841470. PubMed ID: 35309346
[TBL] [Abstract][Full Text] [Related]
3. Reduced human leukocyte antigen mismatching is associated with more favourable outcomes after unrelated donor haematopoietic stem cell transplantation.
Valatkaite-Rakstiene B; Cekauskiene R; Zvirblis T; Jakubauskas A
Int J Immunogenet; 2024 Apr; 51(2):63-71. PubMed ID: 38183417
[TBL] [Abstract][Full Text] [Related]
4. HLA-DPB1 matching in unrelated hematopoietic stem cell transplantation program contributes to a higher incidence of disease relapse.
Burek Kamenaric M; Maskalan M; Grubic Z; Mikulic M; Serventi Seiwerth R; Durakovic N; Vrhovac R; Stingl Jankovic K; Zunec R
Hum Immunol; 2017 Nov; 78(11-12):665-671. PubMed ID: 28887054
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
[TBL] [Abstract][Full Text] [Related]
6. [The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation].
He J; Xu C; Wu XJ; Bao XJ; Qiu QC; Yuan XN; Li Y; Shen HJ; Wu DP; Hong JL; Liu JH; DU HY; Zhang L; DU D; Lu J; Liu J
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):353-7. PubMed ID: 22781790
[TBL] [Abstract][Full Text] [Related]
7. Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms.
Bettens F; Passweg J; Schanz U; Chalandon Y; Heim D; Güngör T; Stussi G; Nicoloso G; Baldomero H; Gratwohl A; Tiercy JM
Biol Blood Marrow Transplant; 2012 Apr; 18(4):608-16. PubMed ID: 21963878
[TBL] [Abstract][Full Text] [Related]
8. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
Pidala J; Lee SJ; Ahn KW; Spellman S; Wang HL; Aljurf M; Askar M; Dehn J; Fernandez Viña M; Gratwohl A; Gupta V; Hanna R; Horowitz MM; Hurley CK; Inamoto Y; Kassim AA; Nishihori T; Mueller C; Oudshoorn M; Petersdorf EW; Prasad V; Robinson J; Saber W; Schultz KR; Shaw B; Storek J; Wood WA; Woolfrey AE; Anasetti C
Blood; 2014 Oct; 124(16):2596-606. PubMed ID: 25161269
[TBL] [Abstract][Full Text] [Related]
9. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
[TBL] [Abstract][Full Text] [Related]
10. HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation.
Roerden M; Nelde A; Heitmann JS; Klein R; Rammensee HG; Bethge WA; Walz JS
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32650450
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.
Moyer AM; Hashmi SK; Kroning CM; Kremers WK; De Goey SR; Patnaik M; Litzow M; Gastineau DA; Hogan WJ; Jacob EK; Kreuter JD; Wakefield LL; Gandhi MJ
Eur J Haematol; 2017 Sep; 99(3):275-282. PubMed ID: 28632323
[TBL] [Abstract][Full Text] [Related]
12. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.
Fleischhauer K; Shaw BE; Gooley T; Malkki M; Bardy P; Bignon JD; Dubois V; Horowitz MM; Madrigal JA; Morishima Y; Oudshoorn M; Ringden O; Spellman S; Velardi A; Zino E; Petersdorf EW;
Lancet Oncol; 2012 Apr; 13(4):366-74. PubMed ID: 22340965
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial.
Finke J; Schmoor C; Bethge WA; Ottinger HD; Stelljes M; Zander AR; Volin L; Heim DA; Schwerdtfeger R; Kolbe K; Mayer J; Maertens JA; Linkesch W; Holler E; Koza V; Bornhäuser M; Einsele H; Bertz H; Grishina O; Socié G;
Biol Blood Marrow Transplant; 2012 Nov; 18(11):1716-26. PubMed ID: 22713691
[TBL] [Abstract][Full Text] [Related]
14. Alternative donor strategy in unrelated hematopoietic stem cell transplantation - outcome with mismatched donors.
Grubic Z; Maskalan M; Burek Kamenaric M; Desnica L; Mikulic M; Stingl Jankovic K; Durakovic N; Serventi Seiwerth R; Vrhovac R; Zunec R
Adv Med Sci; 2023 Sep; 68(2):332-340. PubMed ID: 37741003
[TBL] [Abstract][Full Text] [Related]
15. Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantation.
Rockstroh A; Al-Ali HK; Lange T; Pönisch W; Krahl R; Cross M; Behre G; Niederwieser D; Pfrepper C
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2193-203. PubMed ID: 26129640
[TBL] [Abstract][Full Text] [Related]
16. Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation.
Zou J; Kongtim P; Oran B; Kosmoliaptsis V; Carmazzi Y; Ma J; Li L; Rondon G; Srour S; Copley HC; Partlow D; Ciurea SO; Greenbaum U; Ma Q; Shpall EJ; Champlin RE; Cao K
Haematologica; 2022 Apr; 107(4):844-856. PubMed ID: 34435482
[TBL] [Abstract][Full Text] [Related]
17. HLA-DP diversity is associated with improved response to SARS-Cov-2 vaccine in hematopoietic stem cell transplant recipients.
Villemonteix J; Allain V; Verstraete E; Jorge-Cordeiro D; Socié G; Xhaard A; Feray C; Caillat-Zucman S
iScience; 2023 May; 26(5):106763. PubMed ID: 37168557
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci.
Ciurea SO; Saliba RM; Rondon G; Patah PA; Aung F; Cano P; Andersson BS; Kebriaei P; Popat U; Fernandez-Vina M; Champlin RE; de Lima M
Biol Blood Marrow Transplant; 2011 Jun; 17(6):923-9. PubMed ID: 20969970
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744
[TBL] [Abstract][Full Text] [Related]
20.
Tsamadou C; Engelhardt D; Platzbecker U; Sala E; Valerius T; Wagner-Drouet E; Wulf G; Kröger N; Murawski N; Einsele H; Schaefer-Eckart K; Freitag S; Casper J; Kaufmann M; Dürholt M; Hertenstein B; Klein S; Ringhoffer M; Frank S; Neuchel C; Schrezenmeier H; Mytilineos J; Fuerst D
Front Immunol; 2021; 12():771449. PubMed ID: 34970261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
